UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
Apple
AAPL
|
+$21.9B |
| 2 |
Amazon
AMZN
|
+$15.2B |
| 3 |
NVIDIA
NVDA
|
+$4.85B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$2.03B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.67B |
Top Sells
| 1 |
Microsoft
MSFT
|
+$26B |
| 2 |
Equinix
EQIX
|
+$803M |
| 3 |
NetEase
NTES
|
+$723M |
| 4 |
Digital Realty Trust
DLR
|
+$699M |
| 5 |
Bank of New York Mellon
BK
|
+$653M |
Sector Composition
| 1 | Technology | 31.92% |
| 2 | Financials | 13.89% |
| 3 | Consumer Discretionary | 11.31% |
| 4 | Healthcare | 10.69% |
| 5 | Communication Services | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Amphastar Pharmaceuticals
AMPH
$1.3B
| $2.15M | ﹤0.01% |
93,652
+14,563
| +18% | +$334K |
|
2102
Root
ROOT
$1.53B
| $2.15M | ﹤0.01% |
16,781
+8,745
| +109% | +$1.12M |
|
|
ETWO
2103
DELISTED
E2open Parent Holdings
ETWO
| $2.15M | ﹤0.01% |
664,705
+166,580
| +33% | +$538K |
|
2104
Capitol Federal Financial
CFFN
$839M
| $2.15M | ﹤0.01% |
351,859
+118,287
| +51% | +$722K |
|
2105
Bloomin' Brands
BLMN
$577M
| $2.14M | ﹤0.01% |
248,101
+52,147
| +27% | +$449K |
|
2106
Tidewater
TDW
$2.93B
| $2.13M | ﹤0.01% |
46,130
+1,297
| +3% | +$59.8K |
|
2107
Transcat
TRNS
$697M
| $2.13M | ﹤0.01% |
24,752
+4,498
| +22% | +$387K |
|
|
RC
2108
Ready Capital
RC
$689M
| $2.13M | ﹤0.01% |
486,748
+44,316
| +10% | +$194K |
|
2109
InMode
INMD
$937M
| $2.12M | ﹤0.01% |
147,046
+28,334
| +24% | +$409K |
|
|
INVX
2110
Innovex International, Inc.
INVX
$1.14B
| $2.12M | ﹤0.01% |
135,586
+37,361
| +38% | +$584K |
|
2111
Bausch Health
BHC
$2.68B
| $2.11M | ﹤0.01% |
317,268
-7,579
| -2% | -$50.5K |
|
2112
Metropolitan Bank Holding Corp
MCB
$807M
| $2.11M | ﹤0.01% |
30,142
+13,136
| +77% | +$920K |
|
2113
Golden Entertainment
GDEN
$638M
| $2.11M | ﹤0.01% |
71,528
+10,141
| +17% | +$298K |
|
2114
Anavex Life Sciences
AVXL
$805M
| $2.1M | ﹤0.01% |
227,741
+129,107
| +131% | +$1.19M |
|
2115
Castle Biosciences
CSTL
$621M
| $2.1M | ﹤0.01% |
102,742
+34,711
| +51% | +$709K |
|
2116
Evolv Technologies
EVLV
$1.51B
| $2.09M | ﹤0.01% |
335,392
+143,551
| +75% | +$896K |
|
2117
MarineMax
HZO
$556M
| $2.09M | ﹤0.01% |
83,080
+34,570
| +71% | +$869K |
|
2118
HealthStream
HSTM
$855M
| $2.08M | ﹤0.01% |
75,351
+20,997
| +39% | +$581K |
|
2119
Kforce
KFRC
$567M
| $2.08M | ﹤0.01% |
50,506
+11,090
| +28% | +$456K |
|
2120
Udemy
UDMY
$1.08B
| $2.07M | ﹤0.01% |
294,356
+89,040
| +43% | +$626K |
|
2121
Quanex
NX
$661M
| $2.07M | ﹤0.01% |
109,361
+33,134
| +43% | +$626K |
|
2122
ImmunityBio
IBRX
$2.46B
| $2.06M | ﹤0.01% |
781,800
+349,459
| +81% | +$923K |
|
|
VERV
2123
DELISTED
Verve Therapeutics
VERV
| $2.06M | ﹤0.01% |
183,610
+50,044
| +37% | +$562K |
|
2124
Enviri
NVRI
$983M
| $2.06M | ﹤0.01% |
237,016
+80,302
| +51% | +$697K |
|
2125
SunCoke Energy
SXC
$654M
| $2.06M | ﹤0.01% |
239,335
+82,138
| +52% | +$706K |
|